Evidence map›Paper›PMID 41519760›Full record

ArticleCell communication and signaling : CCS2026

Mechanoresponsive ion channels Piezo1 and TRPV4 stimulate ADAM10 and ADAM17 with differential impact on endothelial migration and proliferation.

Alessa Pabst, Nathalie Brock, Sofie Hardt, Caroline C F Grannemann, Hannah Kubiza, Anja Lena Thiebes, Andreas Ludwig, Aaron Babendreyer

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alessa PabstInstitute of Molecular Pharmacology, University Hospital RWTH Aachen, Aachen, Germany. alessa.pabst@rwth-aachen.de.
Nathalie BrockInstitute of Molecular Pharmacology, University Hospital RWTH Aachen, Aachen, Germany.
Sofie HardtInstitute of Molecular Pharmacology, University Hospital RWTH Aachen, Aachen, Germany.
Caroline C F GrannemannInstitute of Molecular Pharmacology, University Hospital RWTH Aachen, Aachen, Germany.
Hannah KubizaDepartment of Biohybrid & Medical Textiles, Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University, Aachen, Germany.
Anja Lena ThiebesDepartment of Biohybrid & Medical Textiles, Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University, Aachen, Germany.
Andreas LudwigInstitute of Molecular Pharmacology, University Hospital RWTH Aachen, Aachen, Germany.
Aaron BabendreyerInstitute of Molecular Pharmacology, University Hospital RWTH Aachen, Aachen, Germany. ababendreyer@ukaachen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndothelial cells are constantly exposed to mechanical forces generated by blood flow regulating endothelial homeostasis. Pathological events such as vascular injury or thrombus formation alter these forces, which are sensed by endothelial cells and can trigger repair mechanisms, including inflammation, proliferation and migration. The mechanical changes can be detected by cells through various mechanosensors, particularly ion channels such as Piezo1 and transient receptor potential vanilloid 4 (TRPV4). One possible pathway for the translation of mechanical signals into cellular responses involves the downstream activation of membrane-bound proteases of the a disintegrin and metalloprotease (ADAM) family. These proteases cleave transmembrane proteins such as growth factors, adhesion molecules and cytokines, thereby regulating inflammation, proliferation and migration. This study aimed to investigate the link between the ion channels Piezo1/TRPV4 and the metalloproteases ADAM10/17.

methodsPrimary human umbilical vein endothelial cells (HUVECs) were treated with pharmacological agonists of Piezo1 and TRPV4 or cultured under flow conditions for mechanical stimulation. Pharmacological inhibitors and shRNA-mediated knockdown were used to assess the involvement of specific proteins. ADAM activity was determined indirectly by measuring the release of substrates such as junctional adhesion molecule A (JAM-A) or tumor necrosis factor receptor 1 (TNFR1) into the culture medium or by a reduction in the cell lysates via ELISA, on the cell surface by flow cytometry, and in the immunocytochemical staining of vascular endothelial cadherin (VE-cadherin). The effects on cell proliferation and migration were analyzed via live-cell microscopy or via proliferation marker genes.

resultsMechanical stimulation through flow induced the activation of ADAM10 and ADAM17, which was partially mediated by Piezo1 and TRPV4. This connection was confirmed via the use of specific agonists for both ion channels, which have the potential to independently activate ADAM proteases. Furthermore, specifically Piezo1 activation led to ADAM10/17-dependent increases in proliferation and migration.

conclusionPiezo1 and TRPV4 contribute to the mechanical activation of ADAM10/17 in endothelial cells and thus may play an important role in regulating endothelial functions. As shown for the regulation of endothelial proliferation and migration by the Piezo1-ADAM axis.

Indexed as

ADAM10 ProteinADAM17 ProteinAmyloid Precursor Protein SecretasesCell MovementIon ChannelsMechanotransduction, CellularMembrane ProteinsTRPV Cation ChannelsCell ProliferationHumansHuman Umbilical Vein Endothelial CellsADAM10 ProteinADAM10 protein, humanADAM17 ProteinADAM17 protein, humanAmyloid Precursor Protein SecretasesIon ChannelsMembrane ProteinsPIEZO1 protein, humanTRPV4 protein, humanTRPV Cation ChannelsADAMsAdhesion moleculesMechanosensitive ion channelMechanotransductionMetalloproteinaseShear stressSheddingTNFR1

Identifiers

PMID41519760
PMCPMC12849641

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.